Market Closed -
Other stock markets
|
After market 02:26:58 pm | |||
80.9 EUR | +0.31% | 80.95 | +0.06% |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Mar. 07 | Rovi explores sale of unit that makes drugs for third parties | RE |
Chart calendar Laboratorios Farmaceuticos Rovi, S.A.
Upcoming events on Laboratorios Farmaceuticos Rovi, S.A.
Past events on Laboratorios Farmaceuticos Rovi, S.A.
2024-02-27 09:00 am | Q4 2023 Earnings Call |
2024-02-26 | Q4 2023 Earnings Release Pre-market |
2023-11-07 | Q3 2023 Earnings Call |
2023-11-07 | Q3 2023 Earnings Release Pre-market |
2023-07-26 09:00 am | Q2 2023 Earnings Call |
2023-07-25 | Q2 2023 Earnings Release Pre-market |
2023-07-02 | Ex-dividend day for final dividend |
2023-06-14 05:00 am | Annual General Meeting |
2023-05-09 | Q1 2023 Earnings Call |
2023-05-09 | Q1 2023 Earnings Release Pre-market |
2023-02-21 04:00 am | FY 2022 Earnings Call |
2023-02-20 | FY 2022 Earnings Release Pre-market |
2022-11-23 04:00 am | Capital Market Day |
2022-11-03 | Q3 2022 Earnings Call |
2022-11-03 | Q3 2022 Earnings Release Pre-market |
2022-07-27 09:00 am | Interim 2022 Earnings Call |
2022-07-26 | Interim 2022 Earnings Release Pre-market |
2022-07-04 | Ex-dividend day for final dividend |
2022-05-10 | Q1 2022 Earnings Call |
2022-05-10 | Q1 2022 Earnings Release Pre-market |
Past dividends on Laboratorios Farmaceuticos Rovi, S.A.
2023-07-02 | Annual 1.047978 EUR |
2022-07-04 | Annual 0.774036 EUR |
2021-07-04 | Annual 0.308772 EUR |
2020-11-16 | Annual 0.141831 EUR |
2019-07-01 | Annual 0.064638 EUR |
2018-07-02 | Annual 0.097767 EUR |
2017-07-02 | Annual 0.14823 EUR |
2016-06-29 | Annual 0.11259 EUR |
2015-07-01 | Annual 0.1352 EUR |
2014-07-02 | Annual 0.127348 EUR |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 381 369 3.33% | 420 417 0.78% | 649 633 2.52% | 818 788 3.78% | 830 823 0.79% | 820 |
EBITDA Million EUR | Released Forecast Spread | 60,9 58,2 4.5% | 94,3 88,5 6.59% | 203 193 5.23% | 279 252 10.47% | 245 239 2.36% | 254 |
EBIT Million EUR | Released Forecast Spread | 42,6 40,6 5.11% | 74,7 69,9 6.88% | 181 171 5.95% | 256 230 11.48% | 220 214 2.67% | 227 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 41,9 40,1 4.44% | 72,6 67,9 6.93% | 183 171 7.03% | 258 226 14.07% | 220 217 1.8% | 232 |
Net income Million EUR | Released Forecast Spread | 39,3 36,1 8.71% | 61,1 60,4 1.07% | 153 140 9.42% | 200 183 9.36% | 170 167 2.05% | 174 |
EPS EUR | Released Forecast Spread | 0,71 0,62 15.01% | 1,10 1,09 0.72% | 2,76 2,51 10.05% | 3,73 3,35 11.19% | 3,20 3,12 2.58% | 3,23 |
Announcement Date | 26/02/20 | 24/02/21 | 23/02/22 | 21/02/23 | 27/02/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 191 191 -0.08% | 290 277 4.73% | 185 174 6.55% | 206 201 2.53% | 175 173 1.32% | 380 377 0.78% | 195 193 0.91% | 242 223 8.67% | 202 195 3.15% | 179 174 3.01% | 381 377 1.02% | 214 208 3.05% | 235 226 3.91% |
EBITDA Million EUR | Released Forecast Spread | 42,4 39,8 6.67% | 74,0 74,7 -0.94% | 63,4 55,5 14.09% | 74,3 68,5 8.47% | 41,5 38,5 7.7% | 116 113 2.57% | 58,1 55,2 5.25% | 105 82,1 27.71% | 66,5 59,1 12.57% | 30,6 24,2 26.62% | 97,1 93,0 4.41% | 74,1 66,8 10.93% | 73,3 71,1 3.14% |
EBIT Million EUR | Released Forecast Spread | 32,9 30,3 8.63% | 63,2 65,6 -3.6% | 58,2 49,8 16.8% | 68,7 62,0 10.82% | 35,7 33,2 7.33% | 104 102 2.45% | 52,5 49,6 5.89% | 99,0 74,5 32.91% | 60,7 52,8 14.91% | 24,5 19,0 28.98% | 85,2 81,0 5.19% | 68,2 58,5 16.58% | 66,7 66,0 1.06% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 58,3 44,1 32.15% | 68,9 61,7 11.71% | 61,2 55,3 10.67% | ||||||||||
Net income Million EUR | Released Forecast Spread | 29,6 27,3 8.49% | 51,0 50,1 1.84% | 54,1 36,1 50.18% | 53,0 49,5 7.17% | 27,6 25,5 8.2% | 80,6 78,6 2.57% | 40,9 38,2 7.02% | 78,2 59,8 30.82% | 47,5 42,3 12.29% | 19,1 13,6 40.1% | 66,6 63,0 5.71% | 52,2 45,5 14.77% | 51,5 47,7 8.04% |
EPS EUR | Released Forecast Spread | 0,98 0,61 60.66% | ||||||||||||
Announcement Date | 27/07/20 | 28/07/21 | 23/02/22 | 11/05/22 | 27/07/22 | 27/07/22 | 04/11/22 | 21/02/23 | 10/05/23 | 26/07/23 | 26/07/23 | 08/11/23 | 27/02/24 |
Past sector events for Laboratorios Farmaceuticos Rovi, S.A.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Laboratorios Farmaceuticos Rovi, S.A. - BME
- Calendar Laboratorios Farmaceuticos Rovi, S.A.